ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells

Luo, YJ; Li, W; Ling, ZH; Hu, QC; Fan, Z; Cheng, B; Tao, XA

CANCER MEDICINE, 2020; 9 (10): 3489

Abstract

Background Alanine-serine-cysteine transporter 2 (ASCT2), a major glutamine transporter, is essential for cell growth and tumor development in a varie......

Full Text Link